TY - JOUR
T1 - Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection
AU - Zhang, Weijia
AU - Yi, Zhengzi
AU - Wei, Chengguo
AU - Keung, Karen L.
AU - Sun, Zeguo
AU - Xi, Caixia
AU - Woytovich, Christopher
AU - Farouk, Samira
AU - Gallon, Lorenzo
AU - Menon, Madhav C.
AU - Magee, Ciara
AU - Najafian, Nader
AU - Samaniego, Milagros D.
AU - Djamali, Arjang
AU - Alexander, Stephen I.
AU - Rosales, Ivy A.
AU - Smith, Rex Neal
AU - O’Connell, Philip J.
AU - Colvin, Robert
AU - Cravedi, Paolo
AU - Murphy, Barbara
N1 - Publisher Copyright:
Copyright: © 2019 American Society for Clinical Investigation
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/6/6
Y1 - 2019/6/6
N2 - Commonly available clinical parameters fail to predict early acute cellular rejection (EAR, occurring within 6 months after transplant), a major risk factor for graft loss after kidney transplantation. We performed whole-blood RNA sequencing at the time of transplant in 235 kidney transplant recipients enrolled in a prospective cohort study (Genomics of Chronic Allograft Rejection [GoCAR]) and evaluated the relationship of pretransplant transcriptomic profiles with EAR. EAR was associated with downregulation of NK and CD8+ T cell gene signatures in pretransplant blood. We identified a 23-gene set that predicted EAR in the discovery (n = 81, and AUC = 0.80) and validation (n = 74, and AUC = 0.74) sets. Exclusion of recipients with 5 or 6 HLA donor mismatches increased the AUC to 0.89. The risk score derived from the gene set was also significantly associated with acute cellular rejection after 6 months, antibody-mediated rejection and/or de novo donor-specific antibodies, and graft loss in a cohort of 154 patients, combining the validation set and additional GoCAR patients with surveillance biopsies between 6 and 24 months (n = 80) posttransplant. This 23-gene set is a potentially important new tool for determination of the recipient’s immunological risk before kidney transplantation, and facilitation of an individualized approach to immunosuppressive therapy.
AB - Commonly available clinical parameters fail to predict early acute cellular rejection (EAR, occurring within 6 months after transplant), a major risk factor for graft loss after kidney transplantation. We performed whole-blood RNA sequencing at the time of transplant in 235 kidney transplant recipients enrolled in a prospective cohort study (Genomics of Chronic Allograft Rejection [GoCAR]) and evaluated the relationship of pretransplant transcriptomic profiles with EAR. EAR was associated with downregulation of NK and CD8+ T cell gene signatures in pretransplant blood. We identified a 23-gene set that predicted EAR in the discovery (n = 81, and AUC = 0.80) and validation (n = 74, and AUC = 0.74) sets. Exclusion of recipients with 5 or 6 HLA donor mismatches increased the AUC to 0.89. The risk score derived from the gene set was also significantly associated with acute cellular rejection after 6 months, antibody-mediated rejection and/or de novo donor-specific antibodies, and graft loss in a cohort of 154 patients, combining the validation set and additional GoCAR patients with surveillance biopsies between 6 and 24 months (n = 80) posttransplant. This 23-gene set is a potentially important new tool for determination of the recipient’s immunological risk before kidney transplantation, and facilitation of an individualized approach to immunosuppressive therapy.
UR - http://www.scopus.com/inward/record.url?scp=85070659158&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070659158&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.127543
DO - 10.1172/jci.insight.127543
M3 - Article
C2 - 31167967
AN - SCOPUS:85070659158
VL - 4
JO - JCI insight
JF - JCI insight
SN - 2379-3708
IS - 11
M1 - e127543
ER -